Microwave Ablation of Resectable Liver Tumors



Status:Recruiting
Conditions:Liver Cancer, Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:4/2/2016
Start Date:April 2009
Contact:Gitana Davila
Email:Gitana.Davila@stjoe.org
Phone:714-734-6220

Use our guide to learn which trials are right for you!

The purpose of this protocol is to pathologically evaluate the destruction by microwave
ablation of primary and metastatic liver tumors. The primary aim is to measure tissue
destruction with the MedWaves Microwave Ablation/ Coagulation Ablation System.

Minimally invasive surgical alternatives are becoming more attractive for the treatment of
malignancy.The goal is to reduce morbidity and mortality and increase the ability to treat
patients in the outpatient setting. Image-guided ablation is becoming an attractive
alternative because of its relative low cost, its ability to provide large regions of
coagulative necrosis in a controlled fashion, and its relatively low toxicity. Although
image-guided ablative techniques have been extensively investigated for the treatment of
liver tumors, there has been limited experience with microwave ablation (MWA) in the liver.
This study will evaluate the treatment effect of MWA in liver tumors. Patients undergoing
planned surgical removal of liver tumors will have the tumors intra-operatively treated with
MWA. The histological changes will be evaluated upon removal of the specimen.

Inclusion Criteria:

- Diagnosis of primary or metastatic liver cancer for which surgery is planned

- All participants need to be fully able to give informed consent

Exclusion Criteria:

- Mental or legal incompetence

- Impaired decision-making capacity

- Pregnant women may not participate
We found this trial at
1
site
?
mi
from
Orange, CA
Click here to add this to my saved trials